New drug trial aims to halt debilitating 'Second Skeleton' disease
Disease control
Ongoing
This study is testing an experimental drug called andecaliximab for people with fibrodysplasia ossificans progressiva (FOP), a rare and severe condition where muscles and soft tissues turn into bone. The main goal is to see if the drug can safely reduce the formation of new, abno…
Phase: PHASE2, PHASE3 • Sponsor: Ashibio Inc • Aim: Disease control
Last updated Mar 03, 2026 14:06 UTC